Hyperliquid Strategies Inc — Form S-1
Filed September 14, 2026 · analyzed by the Registration Agent
S-1
▼ Likely negative
significance 72/100
What the filing says
Hyperliquid Strategies amended its ChEF Purchase Agreement with Chardan Capital Markets LLC (dated October 22, 2025) on September 14, 2026. The amendment permits Chardan to purchase up to 160 million shares of common stock at 98.5% of VWAP (volume-weighted average price) for standard purchases or 97% for off-hours purchases. After the first 160M shares are sold under this agreement, the discount structure takes effect. The company retains sole discretion over whether and when to issue shares to Chardan.
Why this rating
160M shares at current implied $2.76/share valuation (~$441.8M market cap) represents ~36% dilution potential. The discounted VWAP pricing (1.5–3% below market) and Chardan's optionality structure create ongoing dilution risk and downward pricing pressure, material to equity holders despite company's issuance discretion.
Price action (we called it negative)
at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.